Introduction
Accumulating lines of evidence suggest that reactive oxygen species (ROS) formation and the subsequent inflammatory processes induced by humoral factors and mechanical forces play an integral role in the pathogenesis of vascular diseases, such as atherosclerosis and hypertension (1, 2) . Among such humoral factors, angiotensin (Ang) II is the most extensively studied and characterized (1, 3, 4) . Ang II, via its type 1 (AT1) receptor, activates β-nicotinamide adenine dinucleotide (phosphate)-reduced (NAD(P)H) oxidase to increase intracellular ROS production in vascular cells, which in turn contributes to vascular inflammation (5) by upregulating an entire set of redox-sensitive genes, including adhesion molecules (intercellular adhesion molecule-1: ICAM-1; vascular adhesion molecule-1: VCAM-1), pro-inflammatory molecules (monocyte chemoattractant protein-1: MCP-1; osteopontin) and coagulation/antifibrinolytic factors (plasminogen activator-1: PAI-1; tissue factor) (6, 7) . These events lead to mono-cyte adhesion, activation, and thrombosis, thereby resulting in endothelial dysfunction and progression of atherosclerosis (6−8) .
Adrenomedullin (AM), a potent vasodilator peptide originally isolated from human pheochromocytoma (9) , has recently been shown to be abundantly expressed by and secreted from vascular endothelial cells (ECs) in an autocrine/ paracrine fashion (10) . AM has pleiotropic effects, including cell growth, migration, apoptosis, inflammation, angiogenesis, and hormone secretion (11, 12) . AM-deficient mice loaded with Ang II and high-salts have recently been shown to exhibit perivascular inflammation in the coronary arteries with increased oxidative stress, which effects are reversed by AM supplementation (13) , suggesting that AM may protect against oxidative stress in vivo. However, the underlying cellular mechanism of the antioxidant effects of AM remains to be clarified.
These observations led us to examine whether AM directly affects the intracellular ROS generation stimulated by Ang II in rat aortic ECs in vitro, and whether AM has any antioxidant effect on Ang II-induced redox-sensitive gene expression.
Methods

Materials
Ang II, rat AM and calcitonin gene related peptide (CGRP) 8-37 were purchased from the Peptide Institute (Osaka, Japan). Medium199 (M199) was from Invitrogen (Carlsbad, USA), and fetal bovine serum (FBS) and calf serum (CS) were purchased from Cell Culture Laboratories (Cleveland, USA).
, and 8-bromoadenosine-3′,5′-cyclic monophophate (8-bromo-cAMP) were from Sigma (St. Louis, USA). Polymerase chain reaction (PCR) primers were synthesized by JbioS Inc. (Saitama, Japan).
Cell Culture
Rat aortic ECs were prepared from the thoracic aorta of 6-week-old male Sprague-Dawley (SD) rats using the explant method and cultured as previously described (14) . Confluent cells from passages 5 to 7 were subjected to serum starvation (M199 with 0.5% CS) for 24 h and then used for experiments.
Measurement of Intracellular ROS Levels
Intracellular ROS generation was measured in live rat aortic ECs by the method of Ushio-Fukai et al. (4) with some modifications. Briefly, starved cells grown on 35 mm glass-bottom dishes (Matsunami, Tokyo, Japan) were pretreated with test compounds or left untreated for 1 h, and then cultured in the presence or absence of 10 -7 mol/l Ang II. In some experiments, H-89 had been applied to the medium 15 min prior to the AM addition. After 2 h incubation with or without Ang II, cells were incubated with 8 × 10 -6 mol/l hydrogen peroxide (H2O2)-sensitive fluorophore 5 (and 6)-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate, acetyl ester (CM-H2DCFDA) (Molecular Probes Inc., Eugene, USA) for 30 min at 37°C and imaged by inverted fluorescence microscopy (IX71; Olympus, Tokyo, Japan). The relative fluorescent intensities were recorded and analyzed by a charge-coupled device (CCD) Camera (CoolSNAP HQ; Nippon Roper, Chiba, Japan) with an image analysis system (MetaMorph; Nippon Roper).
NAD(P)H Oxidase Activity
NAD(P)H oxidase activity in rat ECs was analyzed by the methods described by Xie et al. (15) with some modifications. Briefly, starved cells grown on 10 cm dishes were pretreated with test compounds or left untreated for 1 h, and then cultured in the presence or absence of 10 -7 mol/l Ang II for 2 h. Then cells were harvested, resuspended in lysis buffer composed of 5 × 10 -2 mol/l phosphate buffer (pH 7.0), 10 -3 mol/l ethyleneglycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA), 10 μg/ml aprotinin, and 10 -3 mol/l phenylmeththyl sulfonylfluoride (PMSF), and dounced 100 times on ice. The lysates were centrifuged at 16,000 × g for 20 min. The membrane fractions (pellet) were resuspended in lysis mol/l sucrose, 2 × 10 -5 mol/l dark-adapted lucigenin with or without 1 × 10 -4 mol/l DPI in a 96-well white assay plate (Corning, Rochester, USA). After preincubation at 37°C for 5 min, NADH (10 -4 mol/l) was added and luminescence was measured with a microplate luminometer (LB96V; Berthold Japan, Tokyo) over 1-min intervals for a total of 15 min. The NAD(P)H oxidase-dependent superoxide anion (O2 -) productions with and without DPI were measured over a period of 15 min by lucigenin chemiluminescence, and NAD(P)H oxidase activity was taken as the difference between the production with DPI and that without DPI.
Quantification of mRNA
Rat ICAM-1, VCAM-1, PAI-1, tissue factor, and osteopontin mRNA levels were quantified with a real-time quantitative reverse transcription−polymerase chain reaction (RT-PCR) using fluorescent SYBR green technology (LightCycler; Roche Molecular Biochemicals, Mannheim, Germany) as described previously (13) . Rat MCP-1 and acid ribosomal phosphoprotein P0 (ARPP P0) mRNA levels were quantified by TaqMan fluorescence methods as described previously (16) , except using a QuantiTect Probe PCR Kit (Qiagen, Hilden, Germany) and LightCycler. Total RNA was extracted, first-strand cDNA synthesized, and the amplification reaction performed as described previously (16) . PCR primers, TaqMan probes and the size of each PCR product are listed in Table 1 .
The mRNA levels of the target sequence were normalized by those of ARPP P0 used as an endogenous internal control; the relative levels of each mRNA to that of ARPP P0 were calculated as shown in each figure.
Statistical Analysis
Data were expressed as the mean±SEM. Differences between groups were examined for statistical significance using either unpaired t-test or one-way analysis of variance (ANOVA) with Dunn's post hoc test as appropriate. p values less than 0.05 were considered statistically significant.
Results
AM Inhibits Ang II-Stimulated ROS Generation
We first examined the effect of AM on ROS generation stimulated by Ang II in rat aortic ECs by measurement of dichlorofluorescein (DCF) fluorescence using microfluorometry. Stimulation with Ang II for 2 h caused a greater increase in
Fig. 1. AM inhibits Ang II-stimulated ROS generation in rat ECs. Representative microscopic images of DCF fluorescence (magnification: × 400) in non-treated cells (control: CTR) (A), Ang II-stimulated cells (B), and Ang II-stimulated cells pretreated with tiron (10 -2 mol/l) (C) or AM (10 -7 mol/l) (D) are shown.
DCF fluorescence compared to that in untreated cells, and this effect was abolished by pretreatment with tiron (10 -2 mol/l), a cell-permeable superoxide radical scavenger, and AM (10 
−10
-7 mol/l) inhibition of the Ang II-stimulated ROS generation, and this effect was completely abolished by H-89 (10 -5 mol/l), a protein kinase A (PKA) inhibitor (Fig. 2) . Treatment with either AM (10 -7 mol/l), DPI (10 -5 mol/l) or H-89 (10 -5 mol/l) alone did not show any effect on basal ROS generation, whereas tiron decreased basal ROS generation in a dose-dependent manner. These data suggest that AM exerts its antioxidant effect by inhibiting Ang II-induced intracellular ROS generation via a PKA-dependent pathway in rat ECs.
AM Directly Inhibits NAD(P)H Oxidase Activity
In order to confirm that the Ang II-stimulated ROS molecules were derived from NAD(P)H oxidase, we measured NAD(P)H oxidase activity by a lucigenin chemiluminescence assay (Fig. 3) . Membrane fractions from rat ECs treated with Ang II showed an approximately 2-fold increase in NAD(P)H oxidase activity compared to those from non-treated cells. Pretreatment with AM induced a dose-dependent (10 -8
−10
-7 mol/l) inhibition of Ang II-stimulated NAD(P)H oxidase activity, and this effect was mimicked by 10 -4 mol/l of 8-bromo-cAMP (Fig. 3) , a dose which increased intracellular cAMP to levels comparable to those stimulated by 10 -7 mol/l of AM (data not shown).
To study whether the AM produced by rat ECs in an autocrine/paracrine fashion affects the Ang II-stimulated NAD(P)H oxidase activity, we also examined the effect of CGRP8-37, an AM/CGRP receptor antagonist, on Ang IIinduced NAD(P)H oxidase activity. The pretreatment with CGRP8-37 (3 × 10 -6 mol/l) tended to increase Ang II-stimulated NAD(P)H oxidase activity compared to that by Ang II without CGRP8-37 pretreatment, although the difference was not statistically significant (Ang II without CGRP8-37: 1.9±0.17; Ang II with CGRP8-37: 2.3±0.15; data are shown as the fold-increase over controls).
AM Inhibits Ang II-Induced Redox-Sensitive Gene Expression
We next examined whether AM affects Ang II-induced gene expression (ICAM-1, VCAM-1, PAI-1, tissue factor, MCP-1, and osteopontin) in ECs using real time RT-PCR. Time course experiments revealed that the maximum mRNA inductions of all the genes in the set were observed at 3 h after Ang II stimulation (data not shown). AM significantly and dose-dependently (10 -8
−10
-7 mol/l) (p< 0.05) blocked the Ang II-induced gene expressions of ICAM-1, VCAM-1, PAI-1 (Fig. 4) , tissue factor, MCP-1, and osteopontin (Fig. 5) , and these inhibitory effects were similarly reversed by pretreatment with either H-89 or CGRP8-37. In addition, the inhibitory effects of AM on the Ang II-induced gene expressions were similar to those by NAC (Figs. 4 and 5) . It is of note that treatment with NAC alone significantly (p< 0.05) increased the steady-state mRNA levels of PAI-1 (Fig. 4) and osteopontin (Fig. 5 ), but not those of other genes, while combined treatment with AM and NAC inhibited the Ang II-induced expressions of the full set of redox-sensitive genes to levels comparable to those by NAC alone (Figs. 4 and 5) . Treatment with AM alone, however, did not affect the steady-state mRNA levels of any of these genes. These results suggest that AM inhibits the Ang II-induced upregulation of the full set of redox-sensitive genes in the same manner as NAC.
Fig. 2. AM inhibits Ang II-stimulated ROS generation from NAD(P)H oxidase in rat ECs
Discussion
Ang II stimulates NAD(P)H oxidase to generate O2 -, which is promptly converted by superoxide dismutase (SOD) to a more stable molecule, H2O2. H2O2 is a major determinant of the intracellular redox-state; it functions as a signaling molecule and is subsequently scavenged by catalase or glutathione peroxidase (6, 17) . The present study showed that tiron potently inhibited both basal and Ang II-stimulated ROS generation and DPI inhibited Ang II-stimulated ROS generation, suggesting that intracellular H2O2 molecules detected by DCF fluorescence are largely derived from O2 -, and Ang II-stimulated ROS molecules are largely derived from NAD(P)H oxidase.
The present findings demonstrated for the first time that AM inhibits NAD(P)H oxidase-derived O2 -generation stimulated by Ang II in rat ECs. These results are consistent with a recent study showing that AM gene transfer inhibits NAD(P)H oxidase activity and decreases superoxide genera- tion in rat myocardial tissues after ischemia and reperfusion injury (18) . Taken together, these results suggest that the O2 -generated from NAD(P)H oxidase is one of the major molecules targeted by AM in exerting its cardiovascular protective effects. It has been suggested that the nitric oxide/cyclicGMP pathway is involved in the cardioprotective mechanism by AM (18) . In contrast, our present study showed that a PKA inhibitor (H-89) completely abolished the AM-induced inhibition of Ang II-stimulated intracellular ROS generation and a cellpermeable cAMP analog (8-bromo-cAMP) mimicked the AM-mediated inhibition of NAD(P)H oxidase. Thus our results strongly suggest that the antioxidant action of AM is mediated via a cAMP/PKA-dependent pathway in rat ECs.
Fig. 3. AM inhibits Ang II-stimulated NAD(P)H oxidase activity in rat ECs. NAD(P)H oxidase activity was deter-
It is now well established that intracellular ROS plays a pivotal role in the regulation of gene expression under different redox states within cells (6, 7) . Furthermore, it has been shown that the gene expression of many pro-inflammatory mediators is regulated in a redox-sensitive manner (1, 6, 7) . In this study, we clearly demonstrated that AM inhibits Ang IIinduced expression of a complete set of redox-sensitive genes, as does a potent antioxidant, NAC. Furthermore, AM suppressed the Ang II-induced expression of all genes in the set via a receptor-mediated and PKA-dependent pathway, because an AM/CGRP receptor antagonist and a PKA inhibitor reversed the inhibitory effect by AM on the Ang IIinduced redox-sensitive genes. It has recently been shown that perivascular inflammation in response to Ang II and saltloading is more markedly induced in AM-deficient mice than in wild-type mice (13, 19) . Conversely, it has been shown that oxidative stress increases AM gene expression in vascular smooth muscle cells, suggesting that AM may function as a counter-regulator to oxidative stress (20) . In accordance with the present results, we have very recently reported that AM inhibits Ang II-induced oxidative stress, redox-sensitive c-Jun N-terminal kinase (JNK) activation, and gene expression in vascular smooth muscle cells via a cAMP/PKA-dependent pathway (21) . Taken together, these results strongly suggest that AM, through its antioxidant properties, exerts a vasculoprotective effect against Ang II-induced vascular injury, possibly by blocking upregulation of most, and possibly all, proinflammatory mediators in vascular cells.
In the present study, pretreatment with CGRP8-37 tended to increase Ang II-stimulated NAD(P)H oxidase activity, though not to a statistically significant degree, indicating that steady state AM production from rat ECs under the present cell culture conditions is not sufficient to counteract exogenous Ang II-stimulated NAD(P)H oxidase activation. Nevertheless, AM production is known to be enhanced under inflammation, oxidant stress, and atherogenic stimuli (10, 20) , and thus it is possible to speculate that locally increased AM may play a protective role in the cardiovascular injury caused by oxidant stress. However, further studies will be needed to examine this possibility.
In the present study, although both NAC and AM showed almost similar inhibitory effects on Ang II-induced PAI-1 and osteopontin gene expression, NAC by itself somehow induced both gene expressions. It has been shown that certain antioxidants, such as pyrrolidinedithiocarbamate (PDTC) and NAC, paradoxically enhance the activity of some redox-sensitive transcriptional factors, such as AP-1, which is generally activated under various pro-oxidant conditions (22, 23) . Thus, the inhibitory mechanisms responsible for PAI-1 and osteopontin gene expression by AM and NAC may differ from those of other genes. It remains unknown whether the inhibitory effect of AM on Ang II-stimulated redox-sensitive gene expression is related to the cell growth and apoptosis of ECs. We have previously reported that AM had an anti-apoptotic effect on rat ECs, although it did not show any effect on DNA synthesis, cell proliferation, or mitogen-activated protein kinase (MAPK) activation in rat ECs (24). There have been contradictory reports regarding the effect of AM on endothelial cell growth. Two studies have reported that AM promotes endothelial cell growth (25, 26), and another has reported that it inhibits such growth (27). The effect of AM on cellular proliferation varies among different cell types and species, and even within individual cells depending on the cell cycle status (12) . A diversity of signaling pathways by AM in a variety of cells, including cAMP/PKA, MAPK, phosphatidyl inositol-3 kinase, and nitric oxide/cyclicGMP, may also contribute to the different cellular responses.
In conclusion, the present study revealed for the first time that AM directly inhibits Ang II-stimulated NAD(P)H oxidase-derived O2 -generation and subsequent redox-sensitive gene expression via a receptor-mediated and cAMP/PKAdependent mechanism in rat ECs. Thus, our present in vitro data support the contention that AM with its antioxidant actions plays a vasculoprotective role in Ang II-induced vascular injury in vivo (13, 18) . However, the pathophysiological significance of AM as an endogenous antioxidant remains to be determined in oxidative stress-related cardiovascular diseases. 
